PathWest Laboratory Medicine WA Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2009
NCT00895947
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Path West Laboratory Medicine WA

Active Ingredients

Drugs in Phase 2 Trials (2)

interferon alpha-2b (Intron-A) (1 trial)

tea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Kidney Failure, Chronic (Phase 2)

Respiratory Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2